National Changhua University of Education Institutional Repository : Item 987654321/13235
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 6491/11663
造訪人次 : 24647648      線上人數 : 55
RC Version 3.2 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 進階搜尋


題名: Modeling of the in Vivo Kinetics of Antioxidants Delineates Suitable Parameters for Selecting Potential Antioxidant Adjuvants for Cancer Therapy
作者: Yang, Ming-Hua;Chuang, Chao-Ming;Hsieh, Chiu-Lan;Wang, Hui-Er;Chen, Kuan-Chou;Chiu, Wen-Ta;Shih, Chun-Ming;Peng, Robert Y.
貢獻者: 生物技術研究所
關鍵詞: Therapeutic behaviours;Quenching;Complementary therapy;Cancer
日期: 2010-03
上傳時間: 2012-08-07T06:58:15Z
出版者: Informa Healthcare
摘要: To find in vivo behaviors of an antioxidant when used as an adjuvant cancer therapy, a more detailed integrated pharmacokinetic scheme is needed. Major reaction parameters associated with the sequential routes from ingestion to decay of an antioxidant were used in mathematical analysis, which included absorption rate coefficient k(a), quenching rate coefficient of the antioxidant k(q1) and tissue quenching rate coefficient k(r). The model was then treated with computer simulation using cited decay rate coefficients and some assumed parameters. When intestinal absorption rate coefficient k(a) becomes larger, retention time of antioxidant in plasma would be prolonged. moreover, k(a) had no effect on either quenching ability of antioxidants or tissue recovering capability. in quenching plasma ROS, the larger the quenching coefficient k(q1), the shorter peak- and the life-times would be for the secondary free radicals that are formed in primary quenching. Conclusively, it is suggestive to prescribe an antioxidant therapy with an appropriate values of k(a) and larger values of k(q1).
關聯: Pharamceutical Biology, 48(3) :306-317
顯示於類別:[生物技術研究所] 期刊論文


檔案 大小格式瀏覽次數
2020700210033.pdf25KbAdobe PDF424檢視/開啟



DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋